Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.
Autor: | Ben‐Ami, Eytan, Barysauskas, Constance M., Solomon, Sarah, Tahlil, Kadija, Malley, Rita, Hohos, Melissa, Polson, Kathleen, Loucks, Margaret, Severgnini, Mariano, Patel, Tara, Cunningham, Amy, Rodig, Scott J., Hodi, F. Stephen, Morgan, Jeffrey A., Merriam, Priscilla, Wagner, Andrew J., Shapiro, Geoffrey I., George, Suzanne |
---|---|
Předmět: |
LEIOMYOSARCOMA
UTERINE cancer IMMUNOTHERAPY PROGRESSION-free survival TUMORS PHENOTYPES GENE expression CANCER cells THERAPEUTICS CANCER treatment THERAPEUTIC use of monoclonal antibodies AGE distribution CANCER invasiveness CLINICAL trials COMPARATIVE studies DRUG administration DOSE-effect relationship in pharmacology INTRAVENOUS therapy LONGITUDINAL method RESEARCH methodology MEDICAL cooperation PROGNOSIS RESEARCH SURVIVAL analysis (Biometry) TUMOR classification UTERINE tumors EVALUATION research TREATMENT effectiveness RETROSPECTIVE studies KAPLAN-Meier estimator |
Zdroj: | Cancer (0008543X); Sep2017, Vol. 123 Issue 17, p3285-3290, 6p |
Abstrakt: | |
Databáze: | Complementary Index |
Externí odkaz: |